159316 创新药E
已收盘 09-11 15:00:00
资讯
新帖
简况
银华国证港股通创新药ETF发起式联接A基金经理变动:马君不再担任该基金基金经理
证券之星 · 09-12 09:32
银华国证港股通创新药ETF发起式联接A基金经理变动:马君不再担任该基金基金经理
重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线
新浪基金 · 09-11 19:17
重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线
【ETF动向】9月10日港股通创新药ETF汇添富基金跌2.52%,份额减少1.24亿份
证券之星 · 09-11 08:31
【ETF动向】9月10日港股通创新药ETF汇添富基金跌2.52%,份额减少1.24亿份
【ETF动向】9月10日创新药ETF银华基金跌1.91%,份额减少2.38亿份
证券之星 · 09-11 08:02
【ETF动向】9月10日创新药ETF银华基金跌1.91%,份额减少2.38亿份
【ETF动向】9月9日港股通创新药ETF汇添富基金跌2.65%,份额减少2.19亿份
证券之星 · 09-10 08:32
【ETF动向】9月9日港股通创新药ETF汇添富基金跌2.65%,份额减少2.19亿份
【ETF动向】9月9日创新药ETF银华基金跌1.41%,份额增加9000万份
证券之星 · 09-10 08:02
【ETF动向】9月9日创新药ETF银华基金跌1.41%,份额增加9000万份
ETF融资盘点|黄金ETF、港股创新药ETF和恒生中国企业ETF融资净流出额居前
格隆汇 · 09-09
ETF融资盘点|黄金ETF、港股创新药ETF和恒生中国企业ETF融资净流出额居前
【ETF动向】9月7日港股通创新药ETF汇添富基金跌1.41%,份额减少9800万份
证券之星 · 09-08
【ETF动向】9月7日港股通创新药ETF汇添富基金跌1.41%,份额减少9800万份
【ETF动向】9月3日创新药ETF银华基金涨0.95%,份额增加6420万份
证券之星 · 09-04
【ETF动向】9月3日创新药ETF银华基金涨0.95%,份额增加6420万份
【ETF动向】9月3日港股通创新药ETF汇添富基金涨3.35%,份额减少2.45亿份
证券之星 · 09-04
【ETF动向】9月3日港股通创新药ETF汇添富基金涨3.35%,份额减少2.45亿份
两万亿下,地量能否见地价?银行冲高回落,地产接棒发力,华宝基金港股通创新药ETF标的指数上探近3%
新浪基金 · 09-03
两万亿下,地量能否见地价?银行冲高回落,地产接棒发力,华宝基金港股通创新药ETF标的指数上探近3%
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
新浪基金 · 09-03
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
【ETF动向】9月2日创新药ETF银华基金跌0.71%,份额增加1.16亿份
证券之星 · 09-03
【ETF动向】9月2日创新药ETF银华基金跌0.71%,份额增加1.16亿份
【ETF动向】9月2日港股通创新药ETF汇添富基金涨0.28%,份额减少1.73亿份
证券之星 · 09-03
【ETF动向】9月2日港股通创新药ETF汇添富基金涨0.28%,份额减少1.73亿份
【ETF动向】9月1日创新药ETF银华基金涨0.12%,份额增加1.52亿份
证券之星 · 09-02
【ETF动向】9月1日创新药ETF银华基金涨0.12%,份额增加1.52亿份
【ETF动向】9月1日港股通创新药ETF汇添富基金跌1.31%,份额减少1.43亿份
证券之星 · 09-02
【ETF动向】9月1日港股通创新药ETF汇添富基金跌1.31%,份额减少1.43亿份
【ETF动向】8月31日创新药ETF银华基金跌1.62%,份额增加4.09亿份
证券之星 · 09-01
【ETF动向】8月31日创新药ETF银华基金跌1.62%,份额增加4.09亿份
【ETF动向】8月31日港股通创新药ETF汇添富基金跌3.53%,份额减少1.4亿份
证券之星 · 09-01
【ETF动向】8月31日港股通创新药ETF汇添富基金跌3.53%,份额减少1.4亿份
美联储放鹰!港股通创新药全链走低,华宝基金港股通创新药ETF(520880)、港股通医疗ETF(159137)双双重挫
新浪基金 · 08-31
美联储放鹰!港股通创新药全链走低,华宝基金港股通创新药ETF(520880)、港股通医疗ETF(159137)双双重挫
【ETF动向】8月27日港股创新药ETF银华基金涨1.1%,份额减少7000万份
证券之星 · 08-28
【ETF动向】8月27日港股创新药ETF银华基金涨1.1%,份额减少7000万份
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159316","market":"SZ","secType":"STK","nameCN":"创新药E","latestPrice":1.093,"timestamp":1789110201000,"preClose":1.115,"halted":0,"volume":383416300,"delay":0,"changeRate":-0.0197,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.022,"latestTime":"09-11 15:00:00","open":1.098,"high":1.107,"low":1.086,"amount":419000000,"amplitude":0.0188,"askPrice":1.094,"askSize":5704,"bidPrice":1.093,"bidSize":6027,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":1.115,"symbolType":"fund","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":1.227,"lowLimit":1.004,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.28381,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159316","defaultTab":"news","newsList":[{"id":"2666850835","title":"银华国证港股通创新药ETF发起式联接A基金经理变动:马君不再担任该基金基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666850835","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666850835?lang=zh_cn&edition=full","pubTime":"2026-09-12 09:32","pubTimestamp":1789176772,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月12日,银华国证港股通创新药ETF发起式联接(023929)发布公告,马君不再担任该基金基金经理,离任日期为2026年9月12日,变更后银华国证港股通创新药ETF发起式联接(023929)的基金经理为谭普景。截止2026年9月11日,银华国证港股通创新药ETF发起式联接净值为1.0772,较上一日下跌1.62%,近一年下跌29.05%。本文数据来源于银华基金管理股份有限公司公告,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200007378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529140","title":"重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529140","media":"新浪基金","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666529140?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:17","pubTimestamp":1789125420,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线,重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图:港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整?低位埋伏创新药,关注两大投资工具:港股通创新药ETF华宝:紧密跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,前十大权重股占比超七成,龙头属性突出,底层资产是港股,高弹性、T+0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhry5675751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","MEDX","159992","LNGR","06978","BK1161","159316","FLHK","520880","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666974514","title":"【ETF动向】9月10日港股通创新药ETF汇添富基金跌2.52%,份额减少1.24亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666974514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666974514?lang=zh_cn&edition=full","pubTime":"2026-09-11 08:31","pubTimestamp":1789086708,"startTime":"0","endTime":"0","summary":"证券之星消息,9月10日,港股通创新药ETF汇添富基金(159570)跌2.52%,成交额13.87亿元。当日份额减少了1.24亿份,最新份额为148.79亿份,近20个交易日份额减少25.3亿份。当日资金净流出8.67亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为210.03亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.34%,近一个月超额回报为0.13%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100014762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666114925","title":"【ETF动向】9月10日创新药ETF银华基金跌1.91%,份额减少2.38亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666114925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666114925?lang=zh_cn&edition=full","pubTime":"2026-09-11 08:02","pubTimestamp":1789084923,"startTime":"0","endTime":"0","summary":"证券之星消息,9月10日,创新药ETF银华基金(159992)跌1.91%,成交额7.98亿元。当日份额减少了2.38亿份,最新份额为200.75亿份,近20个交易日份额增加2.97亿份。当日资金净流出4.7亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为165.02亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.45%,近一个月超额回报为0.1%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100013796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666568035","title":"【ETF动向】9月9日港股通创新药ETF汇添富基金跌2.65%,份额减少2.19亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666568035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666568035?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:32","pubTimestamp":1789000322,"startTime":"0","endTime":"0","summary":"证券之星消息,9月9日,港股通创新药ETF汇添富基金(159570)跌2.65%,成交额14.84亿元。当日份额减少了2.19亿份,最新份额为150.03亿份,近20个交易日份额减少24.38亿份。当日资金净流出7.99亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为218.69亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.71%,近一个月超额回报为-0.06%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000006856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555530","title":"【ETF动向】9月9日创新药ETF银华基金跌1.41%,份额增加9000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666555530?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:02","pubTimestamp":1788998549,"startTime":"0","endTime":"0","summary":"证券之星消息,9月9日,创新药ETF银华基金(159992)跌1.41%,成交额6.02亿元。当日份额增加了9000万份,最新份额为203.13亿份,近20个交易日份额增加4.84亿份。当日资金净流出1.82亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为169.71亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.57%,近一个月超额回报为0.08%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000005768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666306148","title":"ETF融资盘点|黄金ETF、港股创新药ETF和恒生中国企业ETF融资净流出额居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2666306148","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666306148?lang=zh_cn&edition=full","pubTime":"2026-09-09 09:33","pubTimestamp":1788917606,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665708343","title":"【ETF动向】9月7日港股通创新药ETF汇添富基金跌1.41%,份额减少9800万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2665708343","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665708343?lang=zh_cn&edition=full","pubTime":"2026-09-08 08:31","pubTimestamp":1788827518,"startTime":"0","endTime":"0","summary":"证券之星消息,9月7日,港股通创新药ETF汇添富基金(159570)跌1.41%,成交额9.24亿元。当日份额减少了9800万份,最新份额为152.4亿份,近20个交易日份额减少22.01亿份。当日资金净流出4.81亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为226.28亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.71%,近一个月超额回报为-0%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800005010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807289","title":"【ETF动向】9月3日创新药ETF银华基金涨0.95%,份额增加6420万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664807289?lang=zh_cn&edition=full","pubTime":"2026-09-04 08:04","pubTimestamp":1788480269,"startTime":"0","endTime":"0","summary":"证券之星消息,9月3日,创新药ETF银华基金(159992)涨0.95%,成交额6.45亿元。当日份额增加了6420万份,最新份额为199.67亿份,近20个交易日份额减少6.39亿份。当日资金净流入2.16亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为169.86亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.74%,近一个月超额回报为-0.04%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400007124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807107","title":"【ETF动向】9月3日港股通创新药ETF汇添富基金涨3.35%,份额减少2.45亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664807107?lang=zh_cn&edition=full","pubTime":"2026-09-04 08:02","pubTimestamp":1788480152,"startTime":"0","endTime":"0","summary":"证券之星消息,9月3日,港股通创新药ETF汇添富基金(159570)涨3.35%,成交额21.42亿元。当日份额减少了2.45亿份,最新份额为153.93亿份,近20个交易日份额减少20.42亿份。当日资金净流入2.01亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为229.67亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.77%,近一个月超额回报为-0.18%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400006819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664602879","title":"两万亿下,地量能否见地价?银行冲高回落,地产接棒发力,华宝基金港股通创新药ETF标的指数上探近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664602879","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664602879?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:19","pubTimestamp":1788434340,"startTime":"0","endTime":"0","summary":"量能成为主要制约因素,两市成交额1.76万亿,环比进一步缩量。盘面上,科技赛道整体回调,创新药全天强势,港股通创新药ETF华宝标的指数盘中冲击3%,收涨2.42%。地产接棒发力,地产ETF华宝标的指数涨逾2%,8月28日多项房地产政策文件集中发布,国家加快构建房地产发展新模式态度明确。港股通医疗ETF华宝标的指数CXO含量超50%,逆市涨近1%,连收5日及20日均线。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-03/doc-iniqpzpq4330529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159316","FLHK","161121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664231028","title":"创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!","url":"https://stock-news.laohu8.com/highlight/detail?id=2664231028","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664231028?lang=zh_cn&edition=full","pubTime":"2026-09-03 10:52","pubTimestamp":1788403920,"startTime":"0","endTime":"0","summary":"9月3日,港股创新药链继续活跃,创新药龙头公司领涨,石药集团、中国生物制药双双涨超4%。纯正创新药指数——恒生港股通创新药精选指数一度冲高逾2%,跟踪该指数的港股通创新药ETF华宝盘中再收半年线。中金公司提示,创新药较多公司进入临床数据验证阶段,值得自下而上关注。据统计,港股通创新药ETF华宝覆盖的48家创新药研发公司中,31家上半年实现盈利,归母净利同比正增长的有33家,占比近7成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-03/doc-iniqpkry1034045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0501845795.SGD","IE00B5MMRT66.SGD","LU2039709279.SGD","BK1191","IE00BZ08YS42.EUR","BK1161","LNGR","LU1152091168.USD","520880","LU0067412154.USD","LU1226287792.SGD","LU0072913022.USD","LU1226287875.USD","159316","IE00B031HY20.USD","LU1807302812.USD","01093","BK1521","KURE","LU1152091754.HKD","FLHK","LU1813983027.USD","SG9999004220.SGD","LU1951186391.HKD","BK1574","MEDX","LU0880133367.SGD","LU0315179316.USD","IE00B543WZ88.USD","LU0326950275.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","LU1226288170.HKD","06978","LU0314109678.HKD","LU1960683339.HKD","LU1993786604.SGD","LU1226287529.USD","IBBQ","BK1515","IE00BZ08YT58.USD","LU0140636845.USD","159992","LU1226288253.USD","IE0008369823.USD","LU1008478684.HKD","LU1328277881.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664847849","title":"【ETF动向】9月2日创新药ETF银华基金跌0.71%,份额增加1.16亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664847849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664847849?lang=zh_cn&edition=full","pubTime":"2026-09-03 08:05","pubTimestamp":1788393904,"startTime":"0","endTime":"0","summary":"证券之星消息,9月2日,创新药ETF银华基金(159992)跌0.71%,成交额6.08亿元。当日份额增加了1.16亿份,最新份额为199.03亿份,近20个交易日份额减少3.97亿份。当日资金净流出283.09万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为167.7亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.67%,近一个月超额回报为-0.03%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300006778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664427878","title":"【ETF动向】9月2日港股通创新药ETF汇添富基金涨0.28%,份额减少1.73亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664427878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664427878?lang=zh_cn&edition=full","pubTime":"2026-09-03 08:02","pubTimestamp":1788393768,"startTime":"0","endTime":"0","summary":"证券之星消息,9月2日,港股通创新药ETF汇添富基金(159570)涨0.28%,成交额21.94亿元。当日份额减少了1.73亿份,最新份额为156.38亿份,近20个交易日份额减少17.34亿份。当日资金净流出3526.55万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为227.67亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.56%,近一个月超额回报为-0.06%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300006475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664970862","title":"【ETF动向】9月1日创新药ETF银华基金涨0.12%,份额增加1.52亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664970862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664970862?lang=zh_cn&edition=full","pubTime":"2026-09-02 08:05","pubTimestamp":1788307541,"startTime":"0","endTime":"0","summary":"证券之星消息,9月1日,创新药ETF银华基金(159992)涨0.12%,成交额5.85亿元。当日份额增加了1.52亿份,最新份额为197.86亿份,近20个交易日份额减少3.68亿份。当日资金净流入1.09亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为167.73亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.73%,近一个月超额回报为-0.04%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200006997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664862618","title":"【ETF动向】9月1日港股通创新药ETF汇添富基金跌1.31%,份额减少1.43亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664862618","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664862618?lang=zh_cn&edition=full","pubTime":"2026-09-02 08:03","pubTimestamp":1788307399,"startTime":"0","endTime":"0","summary":"证券之星消息,9月1日,港股通创新药ETF汇添富基金(159570)跌1.31%,成交额18.17亿元。当日份额减少了1.43亿份,最新份额为158.11亿份,近20个交易日份额减少15.61亿份。当日资金净流出5.81亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为228.02亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.51%,近一个月超额回报为-0.05%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200006701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664896118","title":"【ETF动向】8月31日创新药ETF银华基金跌1.62%,份额增加4.09亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664896118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664896118?lang=zh_cn&edition=full","pubTime":"2026-09-01 08:06","pubTimestamp":1788221206,"startTime":"0","endTime":"0","summary":"证券之星消息,8月31日,创新药ETF银华基金(159992)跌1.62%,成交额9.47亿元。当日份额增加了4.09亿份,最新份额为196.34亿份,近20个交易日份额减少5.66亿份。当日资金净流入9684.37万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为166.64亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.74%,近一个月超额回报为-0.04%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100007246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664896988","title":"【ETF动向】8月31日港股通创新药ETF汇添富基金跌3.53%,份额减少1.4亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664896988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664896988?lang=zh_cn&edition=full","pubTime":"2026-09-01 08:03","pubTimestamp":1788221007,"startTime":"0","endTime":"0","summary":"证券之星消息,8月31日,港股通创新药ETF汇添富基金(159570)跌3.53%,成交额25.04亿元。当日份额减少了1.4亿份,最新份额为159.54亿份,近20个交易日份额减少14.18亿份。当日资金净流出10.9亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为233.83亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.72%,近一个月超额回报为-0.15%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100006966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663297420","title":"美联储放鹰!港股通创新药全链走低,华宝基金港股通创新药ETF(520880)、港股通医疗ETF(159137)双双重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2663297420","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663297420?lang=zh_cn&edition=full","pubTime":"2026-08-31 11:15","pubTimestamp":1788146100,"startTime":"0","endTime":"0","summary":"据统计,港股通创新药ETF华宝覆盖的48家创新药研发公司中45家已披露业绩,归母净利同比正增长的有33家,占比超73%。港股通医疗ETF华宝已发布中报的44家成份股公司中35家盈利,占比近80%。全链布局创新药,关注两大T+0交易利器:港股通创新药ETF华宝:被动跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,7成仓位押注研发龙头。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-31/doc-iniqepex7542039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IEI","HMOP","MINT","EDV","NEMD","US3Y.BOND","FAZ","VGSH","SHV","TMF","LIAJ","TLT","GBIL","SPY","US7Y.BOND","RAUS","GOVT","NELS","VGLT","XLRI","VEXC","FLHK","159828","BOXX","159992","JPST","TBT","TBIL","SCHO","US6M.BOND","VGIT","LQD","SHY","SKRE","XBIL","IBBQ","BSV","LNGR","TLTW","IEF","JULD","USHY","UDN","BOND","PBDC","US5Y.BOND","FEM","OOQB","VCSH","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034597","title":"【ETF动向】8月27日港股创新药ETF银华基金涨1.1%,份额减少7000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662034597?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:02","pubTimestamp":1787875373,"startTime":"0","endTime":"0","summary":"证券之星消息,8月27日,港股创新药ETF银华基金(159567)涨1.1%,成交额9.86亿元。当日份额减少了7000万份,最新份额为104.34亿份,近20个交易日份额减少5.94亿份。当日资金净流入7694.79万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为77.88亿元。港股创新药ETF银华基金跟踪标的为国证港股通创新药指数,成立(2024-01-03)以来超额回报为-6.97%,近一个月超额回报为-0.16%,管理人为银华基金公司,基金经理为马君。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800014442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789253107965,"stockEarnings":[{"period":"1week","weight":-0.0753},{"period":"1month","weight":-0.0586},{"period":"3month","weight":0.0865},{"period":"6month","weight":-0.0838},{"period":"1year","weight":-0.3236},{"period":"ytd","weight":-0.1305}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药E,159316,创新药E股票,创新药E股票老虎,创新药E股票老虎国际,创新药E行情,创新药E股票行情,创新药E股价,创新药E股市,创新药E股票价格,创新药E股票交易,创新药E股票购买,创新药E股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}